A Case of Anti-Synthetase Syndrome Successfully Treated with Mycophenolate Mofetil and Rituximab but No Corticosteroids

2Citations
Citations of this article
11Readers
Mendeley users who have this article in their library.

Abstract

A patient with antisynthetase syndrome with pulmonary and muscular involvement was treated with immunosuppressive agents without corticosteroids. Rituximab was added to mycophenolate mofetil therapy with improvement in lung functional and imaging findings and normalization of creatine kinase levels.

Cite

CITATION STYLE

APA

Sieradzka, A. E., Naccini, B., & Fontana, M. (2022). A Case of Anti-Synthetase Syndrome Successfully Treated with Mycophenolate Mofetil and Rituximab but No Corticosteroids. European Journal of Case Reports in Internal Medicine, 9(8). https://doi.org/10.12890/2022_003324

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free